Tekla Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-468,538
| Closed | -$12.2M | – | 186 |
|
|
2021
Q2 | $12.2M | Sell |
468,538
-52,057
| -10% | -$1.35M | 0.4% | 65 |
|
|
2021
Q1 | $16.5M | Buy |
520,595
+249,522
| +92% | +$7.9M | 0.57% | 48 |
|
|
2020
Q4 | $12.6M | Hold |
271,073
| – | – | 0.44% | 67 |
|
|
2020
Q3 | $8.92M | Hold |
271,073
| – | – | 0.33% | 71 |
|
|
2020
Q2 | $7.44M | Buy |
271,073
+50,000
| +23% | +$1.37M | 0.28% | 78 |
|
|
2020
Q1 | $6.62M | Sell |
221,073
-22,410
| -9% | -$671K | 0.3% | 68 |
|
|
2019
Q4 | $6.74M | Buy |
243,483
+68,471
| +39% | +$1.9M | 0.25% | 86 |
|
|
2019
Q3 | $3.19M | Sell |
175,012
-24,061
| -12% | -$438K | 0.14% | 112 |
|
|
2019
Q2 | $4.88M | Sell |
199,073
-17,835
| -8% | -$437K | 0.2% | 92 |
|
|
2019
Q1 | $2.06M | Hold |
216,908
| – | – | 0.08% | 129 |
|
|
2018
Q4 | $1.92M | Hold |
216,908
| – | – | 0.08% | 134 |
|
|
2018
Q3 | $2.44M | Buy |
216,908
+183,513
| +550% | +$2.06M | 0.09% | 138 |
|
|
2018
Q2 | $427K | Buy |
+33,395
| New | +$427K | 0.02% | 171 |
|